[SCHEDULE 13G/A] Picard Medical, Inc. Amended Passive Investment Disclosure
Picard Medical 13G/A: Reporting Persons Hold 0 Shares
Picard Medical, Inc. filing amends a previously submitted Schedule 13G to report that the listed Reporting Persons beneficially own 0 shares of Common Stock, $0.0001 par value (CUSIP 740459102).
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Picard Medical, Inc. filing amends a previously submitted Schedule 13G to report that the listed Reporting Persons beneficially own 0 shares of Common Stock, $0.0001 par value (CUSIP 740459102). The amendment is signed by an attorney-in-fact and dated 06/05/2026.
Key Figures
CUSIP:740459102Par value:$0.0001 per shareShares beneficially owned (each):0 shares+3 more
6 metrics
CUSIP740459102Common Stock class identifier
Par value$0.0001 per shareCommon Stock stated class
Shares beneficially owned (each)0 sharesReported for each Reporting Person
Percent of class (each)0.00%Percent ownership reported for each Reporting Person
Signature date06/05/2026Date signatures executed by attorney-in-fact
Power of Attorney referenced11/13/2025Exhibit filing date authorizing attorney-in-fact
Key Terms
Schedule 13G/A, beneficially owned, Power of Attorney
3 terms
Schedule 13G/Aregulatory
"Amendment No. 1 ) Picard Medical, Inc. Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Power of Attorneyother
"Comments accompanying signature: (1) A Power of Attorney authorizing Randall Schultz"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does the Schedule 13G/A for PMI show any ownership by Sindex or Versa entities?
No. The amendment states each Reporting Person beneficially owns 0 shares of Picard Medical common stock, and lists 0.00% ownership for each entity and individual named in the filing.
What date and signatures appear on the PMI Schedule 13G/A amendment?
The signatures are dated 06/05/2026 and executed by Randall Schultz as attorney-in-fact for each Reporting Person, with a Power of Attorney referenced from a filing dated 11/13/2025.
Which entities are listed as Reporting Persons in the PMI filing?
The filing names Sindex SSI Lending, LLC, Versa Capital Fund III, L.P., Versa FGP-III, L.P., Versa UGP-III, LLC, Versa Capital Group, LLC, and Gregory L. Segall as Reporting Persons.
What class of securities and CUSIP does the PMI amendment cover?
The amendment covers Common Stock, $0.0001 par value per share of Picard Medical, Inc., with CUSIP 740459102, as stated in the filing's item identifying the class and CUSIP.
Does the Schedule 13G/A indicate any percent‑of‑class ownership above 5% for PMI?
No. The filing explicitly records 0.00% ownership for each named Reporting Person and states the group holds ownership of 5 percent or less of a class as required by the form.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Picard Medical, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
740459102
(CUSIP Number)
06/03/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
740459102
1
Names of Reporting Persons
Sindex SSI Lending, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.00 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
740459102
1
Names of Reporting Persons
Versa Capital Fund III, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
740459102
1
Names of Reporting Persons
Versa FGP-III, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
740459102
1
Names of Reporting Persons
Versa UGP-III, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
740459102
1
Names of Reporting Persons
Versa Capital Group, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
740459102
1
Names of Reporting Persons
Gregory L. Segall
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Picard Medical, Inc.
(b)
Address of issuer's principal executive offices:
1992 E. Silverlake Rd. Tucson, AZ, 85713
Item 2.
(a)
Name of person filing:
(1) Sindex SSI Lending, LLC, a Delaware limited liability company ("Sindex")
(2) Versa Capital Fund III, L.P., a Delaware limited partnership ("CF III")
(3) Versa FGP-III, L.P., a Delaware limited partnership ("FGP-III")
(4) Versa UGP-III, LLC, a Delaware limited liability company ("UGP-III")
(5) Versa Capital Group, LLC, a Delaware limited liability company ("Versa")
(6) Gregory L. Segall, an individual ("Mr. Segall" and, together with Sindex, CF III, FGP III, UGP III, and Versa, the "Reporting Persons")
(b)
Address or principal business office or, if none, residence:
c/o Versa Capital Management, LLC
130 N. 18th Street
Suite 315
Philadelphia, PA 19103
(c)
Citizenship:
Mr. Segall is a citizen of the United States. The other Reporting Persons were formed under the laws of the State of Delaware.
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP No.:
740459102
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0
(b)
Percent of class:
Sindex SSI Lending, LLC: 0.00%
Versa Capital Fund III, L.P.: 0.00%
Versa FGP-III, L.P.: 0.00%
Versa UGP-III, LLC: 0.00%
Versa Capital Group, LLC: 0.00%
Gregory L. Segall: 0.00%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0
(ii) Shared power to vote or to direct the vote:
Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0
(iii) Sole power to dispose or to direct the disposition of:
Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0
(iv) Shared power to dispose or to direct the disposition of:
Sindex SSI Lending, LLC: 0
Versa Capital Fund III, L.P.: 0
Versa FGP-III, L.P.: 0
Versa UGP-III, LLC: 0
Versa Capital Group, LLC: 0
Gregory L. Segall: 0
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Sindex SSI Lending, LLC
Signature:
/s/ Randall Schultz
Name/Title:
Randall Schultz, as Attorney-in-Fact for: Sindex SSI Lending, LLC (1)
Date:
06/05/2026
Versa Capital Fund III, L.P.
Signature:
/s/ Randall Schultz
Name/Title:
Randall Schultz, as Attorney-in-Fact for: Versa Capital Fund III, L.P. (1)
Date:
06/05/2026
Versa FGP-III, L.P.
Signature:
/s/ Randall Schultz
Name/Title:
Randall Schultz, as Attorney-in-Fact for: Versa FGP-III, L.P. (1)
Date:
06/05/2026
Versa UGP-III, LLC
Signature:
/s/ Randall Schultz
Name/Title:
Randall Schultz, as Attorney-in-Fact for: Versa UGP-III, LLC (1)
Date:
06/05/2026
Versa Capital Group, LLC
Signature:
/s/ Randall Schultz
Name/Title:
Randall Schultz, as Attorney-in-Fact for: Versa Capital Group, LLC (1)
Date:
06/05/2026
Gregory L. Segall
Signature:
/s/ Randall Schultz
Name/Title:
Randall Schultz, as Attorney-in-Fact for: Gregory L. Segall (1)
Date:
06/05/2026
Comments accompanying signature: (1) A Power of Attorney authorizing Randall Schultz to act on behalf of this entity or individual was filed as Exhibit 2 to the statement on Schedule 13G filed on November 13, 2025.
